Dosing quetiapine in drug-naive first-episode psychosis: A controlled, double-blind, randomized, single-centre study investigating efficacy, tolerability, and safety of 200mg/day vs. 400mg/day of quetiapine fumarate in 141 patients aged 15-25

Gregor E Berger; Tina M Proffitt; Mirabel McConchie; Melissa Kerr; Connie Markulev; Hok Pan Yuen; Colin O'Donnell; Dan L Lubman; Andrea Polari; Stephen J Wood; G Paul Amminger; Patrick D McGorry

Dosing quetiapine in drug-naive first-episode psychosis: A controlled, double-blind, randomized, single-centre study investigating efficacy, tolerability, and safety of 200mg/day vs. 400mg/day of quetiapine fumarate in 141 patients aged 15-25

Gregor E Berger, Tina M Proffitt, Mirabel McConchie, Melissa Kerr, Connie Markulev, Hok Pan Yuen, Colin O'Donnell, Dan L Lubman, Andrea Polari, Stephen J Wood, G Paul Amminger, Patrick D McGorry

Psychology

Research output: Contribution to journal › Article › Research › peer-review

26 Citations (Scopus)

Original language	English
Pages (from-to)	1702 - 1714
Number of pages	13
Journal	Journal of Clinical Psychiatry
Volume	69
Issue number	11
Publication status	Published - 2008

Cite this

Berger, G. E., Proffitt, T. M., McConchie, M., Kerr, M., Markulev, C., Yuen, H. P., O'Donnell, C., Lubman, D. L., Polari, A., Wood, S. J., Amminger, G. P., & McGorry, P. D. (2008). Dosing quetiapine in drug-naive first-episode psychosis: A controlled, double-blind, randomized, single-centre study investigating efficacy, tolerability, and safety of 200mg/day vs. 400mg/day of quetiapine fumarate in 141 patients aged 15-25. Journal of Clinical Psychiatry, 69(11), 1702 - 1714.

Berger, Gregor E ; Proffitt, Tina M ; McConchie, Mirabel et al. / Dosing quetiapine in drug-naive first-episode psychosis: A controlled, double-blind, randomized, single-centre study investigating efficacy, tolerability, and safety of 200mg/day vs. 400mg/day of quetiapine fumarate in 141 patients aged 15-25. In: Journal of Clinical Psychiatry. 2008 ; Vol. 69, No. 11. pp. 1702 - 1714.

@article{3ea7627cd4d34b0db6613df9500dbc1f,

title = "Dosing quetiapine in drug-naive first-episode psychosis: A controlled, double-blind, randomized, single-centre study investigating efficacy, tolerability, and safety of 200mg/day vs. 400mg/day of quetiapine fumarate in 141 patients aged 15-25",

author = "Berger, {Gregor E} and Proffitt, {Tina M} and Mirabel McConchie and Melissa Kerr and Connie Markulev and Yuen, {Hok Pan} and Colin O'Donnell and Lubman, {Dan L} and Andrea Polari and Wood, {Stephen J} and Amminger, {G Paul} and McGorry, {Patrick D}",

year = "2008",

language = "English",

volume = "69",

pages = "1702 -- 1714",

journal = "Journal of Clinical Psychiatry",

issn = "0160-6689",

publisher = "Physicians Postgraduate Press, Inc",

number = "11",

}

Berger, GE, Proffitt, TM, McConchie, M, Kerr, M, Markulev, C, Yuen, HP, O'Donnell, C, Lubman, DL, Polari, A, Wood, SJ, Amminger, GP & McGorry, PD 2008, 'Dosing quetiapine in drug-naive first-episode psychosis: A controlled, double-blind, randomized, single-centre study investigating efficacy, tolerability, and safety of 200mg/day vs. 400mg/day of quetiapine fumarate in 141 patients aged 15-25', Journal of Clinical Psychiatry, vol. 69, no. 11, pp. 1702 - 1714.

Dosing quetiapine in drug-naive first-episode psychosis: A controlled, double-blind, randomized, single-centre study investigating efficacy, tolerability, and safety of 200mg/day vs. 400mg/day of quetiapine fumarate in 141 patients aged 15-25. / Berger, Gregor E; Proffitt, Tina M; McConchie, Mirabel et al.
In: Journal of Clinical Psychiatry, Vol. 69, No. 11, 2008, p. 1702 - 1714.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Dosing quetiapine in drug-naive first-episode psychosis: A controlled, double-blind, randomized, single-centre study investigating efficacy, tolerability, and safety of 200mg/day vs. 400mg/day of quetiapine fumarate in 141 patients aged 15-25

AU - Berger, Gregor E

AU - Proffitt, Tina M

AU - McConchie, Mirabel

AU - Kerr, Melissa

AU - Markulev, Connie

AU - Yuen, Hok Pan

AU - O'Donnell, Colin

AU - Lubman, Dan L

AU - Polari, Andrea

AU - Wood, Stephen J

AU - Amminger, G Paul

AU - McGorry, Patrick D

PY - 2008

Y1 - 2008

M3 - Article

SN - 0160-6689

VL - 69

SP - 1702

EP - 1714

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

IS - 11

ER -

Berger GE, Proffitt TM, McConchie M, Kerr M, Markulev C, Yuen HP et al. Dosing quetiapine in drug-naive first-episode psychosis: A controlled, double-blind, randomized, single-centre study investigating efficacy, tolerability, and safety of 200mg/day vs. 400mg/day of quetiapine fumarate in 141 patients aged 15-25. Journal of Clinical Psychiatry. 2008;69(11):1702 - 1714.